GTP is forging partnerships with technology companies and contract manufacturing organisations to provide its customers with state-of-the art services.
On March 21st 2016, Novasep and GTP Technology announced a partnership which would see them joining forces in the production of mAbs and recombinant proteins. This partnership offers biotech firms full CDMO services at all development stages from gene to end product.
GTP offers know-how in producing mAbs at the proof-of-concept /discovery and early clinical stages. Novasep provides expertise and plant facilities for late stage production. The mid-size capacity and full range of services this partners offers fit closely with customer demand around expertise and fast-track process development. The partnership especially targets mAb production for orphan drugs, ADCs and diagnostics.